Khartis Therapeutics: Funding, Investors & Team (Sep 2026)
Khartis Therapeutics is a biotech company developing oral small-molecule medicines for immune-mediated and chronic diseases.
Khartis Therapeutics has raised $50.0M across 1 funding round on record, the most recent a Series B of $50.0M announced in Aug 2026.
That round is above the $7.5M median round size for United States companies tracked on FundedIQ over the last two years.
Khartis Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Khartis Therapeutics Funding Rounds
Khartis Therapeutics Investors
6 investors are recorded in total; the 5 named above are those the record identifies.
Khartis Therapeutics Founders and Leadership Team
Contact details for the Khartis Therapeutics team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Khartis Therapeutics Funding in Context
Khartis Therapeutics' latest round of $50.0M is above the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Khartis Therapeutics in Biopharma and San Diego
Companies Similar to Khartis Therapeutics
ClinicFlow is an AI voice agent that answers, schedules, and triages phone calls 24/7 for orthopedic, spine,…
Rubi.ai is an AI-powered deal engine for private markets, automating sourcing, screening, CRM, and…
Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed Platform & AI With…
Based in SF & NY we are building the technology stack to solve the experience, trust, and transparency…
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
HiFi Bridge is a cryptocurrency payments platform that allows customers to buy and sell cryptocurrencies,…
Energy Domain is a platform that offers market analysis, an innovative auction system, and promotional…
AI + Open Source OS for MSPs
Steribite is a medical device company focused on developing unique, disposable products that improve patient…
Post ads, Find, Buy and Rent things.
FlexEtc offers flexible warehouse, office, and coworking spaces with all-inclusive pricing and terms for…
Khartis Therapeutics Funding FAQs
What does Khartis Therapeutics do?
Khartis Therapeutics is a biotech company developing oral small-molecule medicines for immune-mediated and chronic diseases.
How much funding has Khartis Therapeutics raised?
Khartis Therapeutics has raised $50.0M across 1 round on record. The most recent is a Series B of $50.0M announced in Aug 2026.
When did Khartis Therapeutics last raise funding?
Khartis Therapeutics' most recent funding round on record is a Series B of $50.0M, announced in Aug 2026.
Who has invested in Khartis Therapeutics?
Investors on record for Khartis Therapeutics include Longwood Fund, Foresite Capital, Lilly Asia Ventures, Alexandria Venture Investments, Forge Life Science Partners. FundedIQ records 6 investors in total.
Who founded Khartis Therapeutics?
FundedIQ lists Craig Murphy (Co-founder & Chief Scientific Officer), Robert Hoffman (Co-Founder, CEO and Head of Research) at Khartis Therapeutics.
Where is Khartis Therapeutics headquartered?
Khartis Therapeutics is based in San Diego, United States.
How many employees does Khartis Therapeutics have?
Khartis Therapeutics is in the 1-10 employee band.
When was Khartis Therapeutics founded?
Khartis Therapeutics was founded in 2023.
About FundedIQ's Khartis Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Khartis Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.